immunotherapies
Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA
June 27, 2024Research and Development MimiVax, Oncology, Orphan Drug Designation, Roswell Park Comprehensive Cancer Center, immunotherapies, oncology
The US Food and Drug Administration (FDA) has granted an expanded Orphan Drug Designation (ODD) for brain cancer immunotherapy SurVaxM, …
GlaxoSmithKline acquires two solid tumor cell therapies from Immatics for $50 million
February 20, 2020Business Services Cancer, cancer cells, celluar immunotherapies, immunotherapies
GlaxoSmithKline has struck a deal to access two Immatics T-cell receptor (TCR) therapeutics. The deal sees GSK pay $50 million …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
